A 49-year-old Omaha woman was sentenced to four years in a federal prison for committing a wire fraud that took more than $4.6 million from Children's Hospital and Medical Center in Omaha in a complicated scheme in which she submitted invoices for Broxcilam, a drug she made up.
Lisa Kwapniowski, who pleaded guilty, was ordered to pay $3.7 million in restitution.
In a news release Monday, U.S. Attorney Joe Kelly said that from 2010-18, Kwapniowski, the former director of pharmacy services for Children’s Hospital, submitted fraudulent invoices from legitimate pharmaceutical suppliers and from a company she created.
Among other things, in early 2012, Kwapniowski set up a business she named RxSynergy and began to submit invoices purported to be for pharmaceuticals and supplies that neither she nor the company provided. A number of the invoices were for a drug called Broxcilam, which was not a real drug.
By 2018, Kwapniowski had submitted at least 227 fraudulent invoices.
The case was investigated by the FBI.